2018 ESC/ESH Guidelines for the management of arterial hypertension

Spiering, Wilko; Burnier, Michel; Simone, Giovanni de; Dominiczak, Anna F.; Mahfoud, Felix; Redón, Josep; Ruilope, Luis; Zanchetti, Alberto; Kerins, Mary; Kjeldsen, Sverre E.; Laurent, Stéphane; Lip, Gregory Y.H.; McManus, Richard J; Narkiewicz, Krzysztof; Ruschitzka, Frank; Schmieder, Roland E.; Desormais, Iléana; Backer, Guy De; Heagerty, Anthony M.; Boutouyrie, Pierre; Caiani, Enrico Gianluca; Chapman, Neil; Cífková, Renata; Cleland, John G.F.; Leeuw, Peter W. de; Dendale, Paul; Diener, Hans‐Christoph; Fagard, Robert; Farsang, Csaba; Ferrini, Marc; Graham, Ian; Grassı, Guıdo; Haller, Hermann; Hobbs, F D Richard; Jennings, Catriona; Kroon, Abraham A.; Messerli, Franz H.; Muiesan, María Lorenza; Nixdorff, Uwe; Perk, Joep; Rimoldi, Stefano F.; Sattar, Naveed; Seferović, Petar; Stanton, Alice; Vardas, Panos; Volpe, Massimo; Waßmann, Sven; Windecker, Stephan; Aboyans, Victor; Agewall, Stefan; Barbato, Emanuele; Bueno, Héctor; Collet, Jean‐Philippe; Coman, Ioan Mircea; Dean, Veronica; Delgado, Victoria; Fitzsimons, Donna; Gaemperli, Oliver; Hindricks, Gerhard; Iung, Bernard; Jüni, Peter; Katus, Hugo A.; Knuuti, Juhani; Lancellotti, Patrizio; Leclercq, Christophe; McDonagh, Theresa A.; Piepoli, Massimo F; Ponikowski, Piotr; Richter, Dimitrios J; Roffi, Marco; Shlyakhto, Evgeny; Simpson, Iain; Sousa‐Uva, Miguel; Zamorano, José Luís; Tsioufis, Costas; Lurbe, Empar; Kreutz, Reinhold; Bochud, Murielle; Rosei, Enrico Agabiti; Azizi, Michel; Januszewics, Andrzej; Kahan, Thomas; Borne, Philippe van de; Williams, Bryan; Borghi, Claudio; Mancia, Giuseppe; Clément, Denis; Coca, António; Manolis, Athanasios; Benkhedda, Salim; Zelveian, Parounak; Siostrzonek, Peter; Najafov, Ruslan; Павлова, О.С.; Pauw, Michel De; Dizdarević-Hudić, Larisa; Raev, Dimitar; Karpettas, Nikos; Linhart, Aleš; Olsen, Michael Hecht; Shaker, Amin Fouad; Metsärinne, Kaj; Vavlukis, Marija; Halimi, Jean‐Michel; Pagava, Zurab; Schunkert, Heribert; Thomopoulos, Costas; Páll, Dénes; Andersen, Karl; Shechter, Michael; Mercuro, Giuseppe; Bajraktari, Gani; Romanova, T.; Saadé, Georges; Šakalytė, Gintarė; Noppe, Stéphanie; Demarco, Daniela Cassar; Caraus, Alexandru; Wittekoek, Janneke; Aksnes, Tonje A.; Jankowski, Piotr; Polónia, Jorge; Vinereanu, Dragoş; Баранова, Е. И.; Foscoli, Marina; Dikić, Ana Djordjević; Fras, Zlatko; Bertomeu‐Martínez, Vicente; Carlberg, Bo; Burkard, Thilo; Sdiri, Wissem; Aydoğdu, Sinan; Weber, Thomas; Lazareva, I.; Backer, Tine De; Sokolović, Šekib; Jelaković, Bojan; Widimský, Jiří; Viigimaa, Margus; Pörsti, Ilkka; Denolle, Thierry; Krämer, Bernhard K.; Stergiou, George S.; Parati, Gianfranco; Trušinskis, Kārlis; Miglinas, Marius; Gerdts, Eva; Tykarski, Andrzej; Rodrigues, Manuel de Carvalho; Dorobanțu, Maria; Чазова, И Е; Lović, Dragan; Filipová, Slavomíra; Brguljan, Jana; Segura, J.; Gottsäter, Anders; Péchère-Bertschi, Antoinette; Erdine, Serap; Sirenko, Yuriy; Brady, Adrian

doi:10.1093/eurheartj/ehy339

Cited by 7,930 publications

(6,770 citation statements)

References 603 publications

Supporting

Mentioning

5,329

Contrasting

Unclassified

979

Order By: Relevance

“…The MS performs very well in the assessment of SBP in SR and was the only device tested with a significant difference in accuracy in SR compared with AF. SBP is the principal measurement for the classification of office BP and definitions of hypertension grade . The study shows that this device can be relied upon to give accurate readings in SR.…”

Section: Discussionmentioning

confidence: 96%

“…Hypertension remains the major preventable cause of cardiovascular disease and all‐cause death globally. Office BP measurement is an European Society of Cardiology (ESC) class I recommendation for the screening and diagnosis of hypertension . The most commonly used assessment of office BP in the UK and worldwide is the AS .…”

Section: Discussionmentioning

confidence: 99%

“…Medical professionals therefore rely upon accurate assessment of BP to make critical management decisions for patients. The classification of BP is based upon a range of readings eg high normal BP ranges from 130‐139/85‐89 mm Hg and Grade 1 hypertension is classed as 140‐159/90‐99 mm Hg . The accurate classification of BP is vital for both prognostic and therapeutic reasons and inaccuracies could result in patients being mismanaged.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

A trial of three non‐invasive blood pressure monitors compared with invasive blood pressure assessment in atrial fibrillation and sinus rhythm

et al. 2019

View full text Add to dashboard Cite

SUMMARY Objective To investigate the accuracy of three non‐invasive blood pressure (BP) devices in atrial fibrillation (AF) compared with invasive arterial BP. Methods One hundred patients aged 45‐90 years, 63% male (50 in AF and 50 age matched controls in sinus rhythm [SR]) were identified with arterial lines measuring beat‐to‐beat BP fluctuation. Non‐invasive BP measurements utilising the manual sphygmomanometer (MS), PulseCor R6.5 (PC) and automated sphygmomanometer (AS) were taken simultaneously with invasive BP in a randomised sequence. This was repeated three times in each patient. Results In SR differences in systolic BP (SBP) for MS, AS and PC were −0.34 mm Hg (95% CI −2.31 to 1.63; P = .733), −3.80 mm Hg (95% CI −5.73 to −1.87; P = .0001) and −3.90 mm Hg (95% CI −5.90 to −1.90; P = .0001) and for diastolic BP (DBP) were 6.02 mm Hg (95% CI 4.39‐7.64; P < .0001), 8.95 mm Hg (95% CI 7.36‐10.55; P < .0001) and 7.54 mm Hg (95% CI 5.89‐9.18; P < .0001), respectively. In AF mean differences in SBP for MS, AS and PC were −7.33 mm Hg (95% CI −9.11 to −5.55; P < .0001), −5.29 mm Hg (95% CI −7.08 to −3.50; P < .0001) and −5.75 mm Hg (95% CI −7.54 to −3.96; P < .0001) respectively and for DBP were 5.28 mm Hg (95% CI 4.03‐6.54; P < .0001), 6.26 mm Hg (95% CI 5.00‐7.52; P < .0001) and 6.89 mm Hg (95% CI 5.64‐8.15; P < .0001) respectively. Conclusions The MS is accurate in SR because of direct assessment of Korotkoff sounds. Non‐invasive BP assessment in AF is significantly less accurate. These findings have important prognostic and therapeutic implications.

show abstract

Section: Discussionmentioning

confidence: 96%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

A trial of three non‐invasive blood pressure monitors compared with invasive blood pressure assessment in atrial fibrillation and sinus rhythm

et al. 2019

View full text Add to dashboard Cite

show abstract

“…It caused approximately 10 million deaths, over 200 million disability-adjusted life years, and was a major contributor to ischemic heart disease and stroke. Hypertension is unfortunately poorly recognized; many people have a high blood pressure but are not aware of it, and if they do get treated they are often very poorly controlled [20]. …”

Section: Hypertension: a J (Ton) Rabelink (The Netherlands)mentioning

confidence: 99%

Nephro Update Europe 2018

Kesel¹

2019

Kidney Dis

View full text Add to dashboard Cite

“…For hypertension, we do not have the equivalent of haemoglobin A1c in diabetes as a marker of long-term control. The next best thing is probably home blood pressure readings 5. Patients who perform regular home blood pressure measurements are also more likely to be taking their medications correctly.…”

mentioning

confidence: 99%

How miraculous blood pressure control can be achieved

Cheung

2019

Postgraduate Medical Journal

View full text Add to dashboard Cite

2018 ESC/ESH Guidelines for the management of arterial hypertension

Cited by 7,930 publications

References 603 publications

A trial of three non‐invasive blood pressure monitors compared with invasive blood pressure assessment in atrial fibrillation and sinus rhythm

A trial of three non‐invasive blood pressure monitors compared with invasive blood pressure assessment in atrial fibrillation and sinus rhythm

Nephro Update Europe 2018

How miraculous blood pressure control can be achieved

Contact Info

Product

Resources

About